申请人:SAMJIN PHARMACEUTICAL CO., LTD.
公开号:US10301291B2
公开(公告)日:2019-05-28
The present invention relates to a novel imidazole derivative having a C-Jun N-terminal kinase (JNK) inhibitory activity and a use thereof. A novel imidazole derivative or a pharmaceutically acceptable salt thereof according to the present invention exhibits an excellent inhibitory activity against C-Jun N-terminal kinase (JNK), and thus it is anticipated that a more fundamental approach and target treatment will be possible in the prevention or treatment of degenerative brain nervous system diseases.
本发明涉及一种具有C-Jun N-末端激酶(JNK)抑制活性的新型咪唑衍生物及其用途。根据本发明的一种新型咪唑衍生物或其药学上可接受的盐对C-Jun N-末端激酶(JNK)具有极好的抑制活性,因此预计在预防或治疗退行性脑神经系统疾病方面将有可能采用更根本的方法和靶向治疗。